Logo image of HCC

WARRIOR MET COAL INC (HCC) Stock Fundamental Analysis

USA - NYSE:HCC - US93627C1018 - Common Stock

64.89 USD
+1.18 (+1.85%)
Last: 10/8/2025, 8:04:00 PM
64.89 USD
0 (0%)
After Hours: 10/8/2025, 8:04:00 PM
Fundamental Rating

5

We assign a fundamental rating of 5 out of 10 to HCC. HCC was compared to 156 industry peers in the Metals & Mining industry. HCC has an average financial health and profitability rating. HCC has a decent growth rate and is not valued too expensively.


Dividend Valuation Growth Profitability Health

6

1. Profitability

1.1 Basic Checks

HCC had positive earnings in the past year.
In the past year HCC had a positive cash flow from operations.
Of the past 5 years HCC 4 years were profitable.
HCC had a positive operating cash flow in each of the past 5 years.
HCC Yearly Net Income VS EBIT VS OCF VS FCFHCC Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M -200M 400M 600M 800M

1.2 Ratios

Looking at the Return On Assets, with a value of 1.52%, HCC is in the better half of the industry, outperforming 64.10% of the companies in the same industry.
The Return On Equity of HCC (1.94%) is better than 62.18% of its industry peers.
HCC's Return On Invested Capital of 0.91% is in line compared to the rest of the industry. HCC outperforms 50.64% of its industry peers.
HCC had an Average Return On Invested Capital over the past 3 years of 23.37%. This is significantly above the industry average of 12.16%.
The last Return On Invested Capital (0.91%) for HCC is well below the 3 year average (23.37%), which needs to be investigated, but indicates that HCC had better years and this may not be a problem.
Industry RankSector Rank
ROA 1.52%
ROE 1.94%
ROIC 0.91%
ROA(3y)20.53%
ROA(5y)13.87%
ROE(3y)27.27%
ROE(5y)18.84%
ROIC(3y)23.37%
ROIC(5y)N/A
HCC Yearly ROA, ROE, ROICHCC Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50 100

1.3 Margins

HCC has a Profit Margin of 3.30%. This is in the better half of the industry: HCC outperforms 66.67% of its industry peers.
In the last couple of years the Profit Margin of HCC has declined.
With a Operating Margin value of 2.08%, HCC perfoms like the industry average, outperforming 51.92% of the companies in the same industry.
HCC's Operating Margin has declined in the last couple of years.
Looking at the Gross Margin, with a value of 20.38%, HCC is in line with its industry, outperforming 59.62% of the companies in the same industry.
In the last couple of years the Gross Margin of HCC has declined.
Industry RankSector Rank
OM 2.08%
PM (TTM) 3.3%
GM 20.38%
OM growth 3Y-15.98%
OM growth 5Y-11.14%
PM growth 3Y4.87%
PM growth 5Y-7.13%
GM growth 3Y-11.66%
GM growth 5Y-5.37%
HCC Yearly Profit, Operating, Gross MarginsHCC Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40 -40

6

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) well above the Cost of Capital (WACC), HCC is creating value.
The number of shares outstanding for HCC has been increased compared to 1 year ago.
The number of shares outstanding for HCC has been reduced compared to 5 years ago.
The debt/assets ratio for HCC has been reduced compared to a year ago.
HCC Yearly Shares OutstandingHCC Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M 50M
HCC Yearly Total Debt VS Total AssetsHCC Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B 2.5B

2.2 Solvency

An Altman-Z score of 5.39 indicates that HCC is not in any danger for bankruptcy at the moment.
HCC's Altman-Z score of 5.39 is fine compared to the rest of the industry. HCC outperforms 63.46% of its industry peers.
A Debt/Equity ratio of 0.10 indicates that HCC is not too dependend on debt financing.
HCC has a Debt to Equity ratio of 0.10. This is comparable to the rest of the industry: HCC outperforms 59.62% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.1
Debt/FCF N/A
Altman-Z 5.39
ROIC/WACC0.1
WACC9.21%
HCC Yearly LT Debt VS Equity VS FCFHCC Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M -500M 1B 1.5B 2B

2.3 Liquidity

HCC has a Current Ratio of 4.59. This indicates that HCC is financially healthy and has no problem in meeting its short term obligations.
HCC has a Current ratio of 4.59. This is in the better half of the industry: HCC outperforms 78.21% of its industry peers.
HCC has a Quick Ratio of 3.44. This indicates that HCC is financially healthy and has no problem in meeting its short term obligations.
HCC has a Quick ratio of 3.44. This is in the better half of the industry: HCC outperforms 71.79% of its industry peers.
Industry RankSector Rank
Current Ratio 4.59
Quick Ratio 3.44
HCC Yearly Current Assets VS Current LiabilitesHCC Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

4

3. Growth

3.1 Past

HCC shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -89.18%.
Measured over the past years, HCC shows a decrease in Earnings Per Share. The EPS has been decreasing by -2.09% on average per year.
Looking at the last year, HCC shows a very negative growth in Revenue. The Revenue has decreased by -27.54% in the last year.
HCC shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 3.76% yearly.
EPS 1Y (TTM)-89.18%
EPS 3Y5.15%
EPS 5Y-2.09%
EPS Q2Q%-91.85%
Revenue 1Y (TTM)-27.54%
Revenue growth 3Y12.92%
Revenue growth 5Y3.76%
Sales Q2Q%-24.97%

3.2 Future

HCC is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 14.20% yearly.
Based on estimates for the next years, HCC will show a quite strong growth in Revenue. The Revenue will grow by 8.17% on average per year.
EPS Next Y-103.18%
EPS Next 2Y5.52%
EPS Next 3Y14.2%
EPS Next 5YN/A
Revenue Next Year-18.53%
Revenue Next 2Y7.17%
Revenue Next 3Y9.83%
Revenue Next 5Y8.17%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
HCC Yearly Revenue VS EstimatesHCC Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 500M 1B 1.5B 2B
HCC Yearly EPS VS EstimatesHCC Yearly EPS VS EstimatesYearly EPS VS Estimates 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 5 10

4

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 72.10, which means the current valuation is very expensive for HCC.
HCC's Price/Earnings ratio is a bit cheaper when compared to the industry. HCC is cheaper than 60.26% of the companies in the same industry.
When comparing the Price/Earnings ratio of HCC to the average of the S&P500 Index (27.91), we can say HCC is valued expensively.
HCC is valuated reasonably with a Price/Forward Earnings ratio of 11.82.
Based on the Price/Forward Earnings ratio, HCC is valued a bit cheaper than 78.85% of the companies in the same industry.
HCC is valuated rather cheaply when we compare the Price/Forward Earnings ratio to 23.30, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 72.1
Fwd PE 11.82
HCC Price Earnings VS Forward Price EarningsHCC Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of HCC indicates a somewhat cheap valuation: HCC is cheaper than 62.18% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 16.69
HCC Per share dataHCC EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 20 30

4.3 Compensation for Growth

HCC has a very decent profitability rating, which may justify a higher PE ratio.
A more expensive valuation may be justified as HCC's earnings are expected to grow with 14.20% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y5.52%
EPS Next 3Y14.2%

3

5. Dividend

5.1 Amount

With a yearly dividend of 0.50%, HCC is not a good candidate for dividend investing.
Compared to an average industry Dividend Yield of 2.45, HCC pays a bit more dividend than its industry peers.
Compared to an average S&P500 Dividend Yield of 2.44, HCC's dividend is way lower than the S&P500 average.
Industry RankSector Rank
Dividend Yield 0.5%

5.2 History

The dividend of HCC decreases each year by -28.78%.
HCC has paid a dividend for at least 10 years, which is a reliable track record.
Dividend Growth(5Y)-28.78%
Div Incr Years0
Div Non Decr Years0
HCC Yearly Dividends per shareHCC Yearly Dividends per shareYearly Dividends per share 2015 2017 2018 2019 2020 2021 2022 2023 2024 2025 2 4 6 8 10

5.3 Sustainability

HCC pays out 42.14% of its income as dividend. This is a bit on the high side, but may be sustainable.
DP42.14%
EPS Next 2Y5.52%
EPS Next 3Y14.2%
HCC Yearly Income VS Free CF VS DividendHCC Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M -200M 400M 600M
HCC Dividend Payout.HCC Dividend Payout, showing the Payout Ratio.HCC Dividend Payout.PayoutRetained Earnings

WARRIOR MET COAL INC

NYSE:HCC (10/8/2025, 8:04:00 PM)

After market: 64.89 0 (0%)

64.89

+1.18 (+1.85%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryMetals & Mining
Earnings (Last)08-06 2025-08-06/amc
Earnings (Next)10-29 2025-10-29/amc
Inst Owners116.28%
Inst Owner Change0%
Ins Owners2.05%
Ins Owner Change0.77%
Market Cap3.41B
Analysts76.67
Price Target68.34 (5.32%)
Short Float %13.04%
Short Ratio6.72
Dividend
Industry RankSector Rank
Dividend Yield 0.5%
Yearly Dividend0.84
Dividend Growth(5Y)-28.78%
DP42.14%
Div Incr Years0
Div Non Decr Years0
Ex-Date08-08 2025-08-08 (0.08)
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-1564%
Min EPS beat(2)-3268.32%
Max EPS beat(2)140.31%
EPS beat(4)2
Avg EPS beat(4)-793.51%
Min EPS beat(4)-3268.32%
Max EPS beat(4)140.31%
EPS beat(8)4
Avg EPS beat(8)-393.55%
EPS beat(12)6
Avg EPS beat(12)-260.73%
EPS beat(16)8
Avg EPS beat(16)-193.59%
Revenue beat(2)2
Avg Revenue beat(2)1.8%
Min Revenue beat(2)0.98%
Max Revenue beat(2)2.62%
Revenue beat(4)3
Avg Revenue beat(4)-0.06%
Min Revenue beat(4)-3.98%
Max Revenue beat(4)2.62%
Revenue beat(8)6
Avg Revenue beat(8)1.64%
Revenue beat(12)8
Avg Revenue beat(12)0.7%
Revenue beat(16)11
Avg Revenue beat(16)3.04%
PT rev (1m)2.03%
PT rev (3m)6.91%
EPS NQ rev (1m)-378.9%
EPS NQ rev (3m)-152.7%
EPS NY rev (1m)-293.75%
EPS NY rev (3m)-120.67%
Revenue NQ rev (1m)0.17%
Revenue NQ rev (3m)-5.61%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-4.1%
Valuation
Industry RankSector Rank
PE 72.1
Fwd PE 11.82
P/S 2.79
P/FCF N/A
P/OCF 20.69
P/B 1.64
P/tB 1.64
EV/EBITDA 16.69
EPS(TTM)0.9
EY1.39%
EPS(NY)5.49
Fwd EY8.46%
FCF(TTM)-5.21
FCFYN/A
OCF(TTM)3.14
OCFY4.83%
SpS23.26
BVpS39.57
TBVpS39.57
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 1.52%
ROE 1.94%
ROCE 1.04%
ROIC 0.91%
ROICexc 1.1%
ROICexgc 1.1%
OM 2.08%
PM (TTM) 3.3%
GM 20.38%
FCFM N/A
ROA(3y)20.53%
ROA(5y)13.87%
ROE(3y)27.27%
ROE(5y)18.84%
ROIC(3y)23.37%
ROIC(5y)N/A
ROICexc(3y)38.43%
ROICexc(5y)N/A
ROICexgc(3y)38.43%
ROICexgc(5y)N/A
ROCE(3y)26.69%
ROCE(5y)N/A
ROICexcg growth 3Y-25.32%
ROICexcg growth 5Y-18.92%
ROICexc growth 3Y-25.32%
ROICexc growth 5Y-18.92%
OM growth 3Y-15.98%
OM growth 5Y-11.14%
PM growth 3Y4.87%
PM growth 5Y-7.13%
GM growth 3Y-11.66%
GM growth 5Y-5.37%
F-Score3
Asset Turnover0.46
Health
Industry RankSector Rank
Debt/Equity 0.1
Debt/FCF N/A
Debt/EBITDA 1.11
Cap/Depr 266.87%
Cap/Sales 35.87%
Interest Coverage 250
Cash Conversion 86.87%
Profit Quality N/A
Current Ratio 4.59
Quick Ratio 3.44
Altman-Z 5.39
F-Score3
WACC9.21%
ROIC/WACC0.1
Cap/Depr(3y)316.54%
Cap/Depr(5y)219.43%
Cap/Sales(3y)25.98%
Cap/Sales(5y)19.86%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-89.18%
EPS 3Y5.15%
EPS 5Y-2.09%
EPS Q2Q%-91.85%
EPS Next Y-103.18%
EPS Next 2Y5.52%
EPS Next 3Y14.2%
EPS Next 5YN/A
Revenue 1Y (TTM)-27.54%
Revenue growth 3Y12.92%
Revenue growth 5Y3.76%
Sales Q2Q%-24.97%
Revenue Next Year-18.53%
Revenue Next 2Y7.17%
Revenue Next 3Y9.83%
Revenue Next 5Y8.17%
EBIT growth 1Y-94.49%
EBIT growth 3Y-5.12%
EBIT growth 5Y-7.8%
EBIT Next Year-28.14%
EBIT Next 3Y35.14%
EBIT Next 5Y28.18%
FCF growth 1Y-172.95%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-78.29%
OCF growth 3Y1.49%
OCF growth 5Y-7.16%